The researchers have conducted a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing technique aimed at ...

CRISPR Therapeutics’ partner Vertex reported that more than 65 treatment centers have been activated for the gene therapy ...

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $38.25, moving +1.38% from the previous trading session.

Dibrugarh: Looking to further India's efforts to eliminate tuberculosis, the ICMR-Regional Medical Research Centre, North ...

Researchers at the University of Minnesota have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) ...

At the same time, the Dow added 1.23%, and the tech-heavy Nasdaq ... At present, CRISPR Therapeutics AG boasts a Zacks Rank of #3 (Hold). The Medical - Biomedical and Genetics industry is part ...

ICMR-RMRC NE transfers TB diagnostic technology to Meril Diagnostics for large-scale commercialisation, aiding India's TB ...

Crispr's emerging technology has led to a new class of therapies ... We think Casgevy's high selling price and the significant unmet medical need for treating sickle-cell disease and transfusion ...

CRISPR-Cas: Pioneering Custom Red Blood Cells for Universal Compatibility. Blood type compatibility has always been a critical factor in medical treatments, particularly in blood ...

In a new study published in Nature, researchers at the University of Chicago Medicine Comprehensive Cancer Center explore a ...

Stylus Medicine, a startup founded by Patrick Hsu, has raised $85 million to develop a suite of technologies that it believes ...

About 150 people in Singapore have transthyretin amyloid cardiomyopathy. Read more at straitstimes.com. Read more at ...